Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000502821 | SCV000595818 | likely benign | not specified | 2021-06-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000860898 | SCV001001075 | likely benign | Congenital amegakaryocytic thrombocytopenia; Essential thrombocythemia | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001357593 | SCV004127908 | likely benign | not provided | 2022-06-01 | criteria provided, single submitter | clinical testing | MPL: BP4, BP7 |
Prevention |
RCV004541562 | SCV004773808 | likely benign | MPL-related disorder | 2023-06-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Department of Pathology and Laboratory Medicine, |
RCV001357593 | SCV001553106 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The MPL p.Thr183Thr variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs147130173) and in ClinVar (classified as a VUS in 2016 by Genetics Services Laboratory, University of Chicago). The variant was identified in control databases in 114 of 282848 chromosomes (1 homozygous) at a frequency of 0.000403 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Latino in 38 of 35438 chromosomes (freq: 0.001072), Ashkenazi Jewish in 6 of 10370 chromosomes (freq: 0.000579), European (non-Finnish) in 58 of 129164 chromosomes (freq: 0.000449), Other in 3 of 7228 chromosomes (freq: 0.000415), South Asian in 7 of 30616 chromosomes (freq: 0.000229), African in 1 of 24962 chromosomes (freq: 0.00004) and European (Finnish) in 1 of 25120 chromosomes (freq: 0.00004); it was not observed in the East Asian population. The variant occurs outside of the splicing consensus sequence however 3 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, GeneSplicer) predict a greater than 10% difference in splicing and the gain of a 3’ splice site. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. | |
Natera, |
RCV001834613 | SCV002086026 | benign | Congenital amegakaryocytic thrombocytopenia | 2020-01-14 | no assertion criteria provided | clinical testing |